Cardiotoxicidad de los Quimioterapéuticos Tipo Antraciclinas de la Lista Oficial de Medicamentos de la Caja Costarricense del Seguro Social.
محفوظ في:
| المؤلفون: | , |
|---|---|
| التنسيق: | artículo original |
| الحالة: | Versión publicada |
| تاريخ النشر: | 2018 |
| الوصف: | Cardiotoxicity associated with the use of chemotherapy has been largely corroborated through multiple clinical trials. In Costa Rica, the development of Cardio-oncologic Units has begun recently in various medical centers with the purpose of achieving an early detection of the deleterious cardiovascular effect associated with different chemotherapeutics. This review consists of a summary of the clinical manifestations related to the use of anthracyclines available in the Costa Rican public health system. |
| البلد: | Portal de Revistas UCR |
| المؤسسة: | Universidad de Costa Rica |
| Repositorio: | Portal de Revistas UCR |
| اللغة: | Español |
| OAI Identifier: | oai:portal.ucr.ac.cr:article/36062 |
| الوصول للمادة أونلاين: | https://revistas.ucr.ac.cr/index.php/clinica/article/view/36062 |